Short Interest in Bonk, Inc. (NASDAQ:BNKK) Expands By 761.1%

Bonk, Inc. (NASDAQ:BNKK) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 834,243 shares, a growth of 761.1% from the April 30th total of 96,882 shares. Based on an average daily volume of 724,730 shares, the short-interest ratio is currently 1.2 days. Currently, 21.5% of the shares of the company are short sold.

Bonk Stock Performance

BNKK stock opened at $1.63 on Thursday. Bonk has a 1 year low of $1.61 and a 1 year high of $46.90. The stock’s 50 day moving average price is $2.47 and its 200 day moving average price is $3.59. The firm has a market cap of $13.04 million, a P/E ratio of -0.35 and a beta of 1.97.

Bonk (NASDAQ:BNKK) last posted its earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The company had revenue of $0.79 million during the quarter.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Wall Street Zen upgraded Bonk from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Weiss Ratings cut Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Insider Buying and Selling at Bonk

In other news, Director Mitchell Austin Rudy bought 31,055 shares of Bonk stock in a transaction dated Thursday, April 9th. The stock was acquired at an average cost of $2.82 per share, with a total value of $87,575.10. Following the acquisition, the director owned 44,198 shares of the company’s stock, valued at approximately $124,638.36. This trade represents a 236.29% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 51.60% of the company’s stock.

Institutional Trading of Bonk

Institutional investors and hedge funds have recently made changes to their positions in the company. State Street Corp acquired a new stake in shares of Bonk during the 4th quarter worth $33,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Bonk during the fourth quarter valued at about $37,000. Jane Street Group LLC acquired a new stake in shares of Bonk during the fourth quarter valued at about $96,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Bonk during the fourth quarter valued at about $128,000. 12.55% of the stock is currently owned by institutional investors and hedge funds.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.